Quick filters
- U.S. District Court Rules Against Merck in NASONEX® (mometasone furoate monohydrate) Patent Lawsuit Business Wire | Friday June 15, 2012 5:05PM
- New Phase III Data Showed Merck's Investigational Insomnia Medicine Suvorexant Improved Patients' Ability to Fall Asleep and Stay Asleep Business Wire | Wednesday June 13, 2012 8:00AM
- Merck to Present at Jefferies 2012 Global Healthcare Conference Business Wire | Friday June 1, 2012 8:00AM
- Merck to Present at Sanford C. Bernstein 28th Strategic Decisions Conference Business Wire | Wednesday May 30, 2012 8:00AM
- Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus Business Wire | Friday May 25, 2012 7:18AM
- Merck Announces Third-Quarter 2012 Dividend Business Wire | Tuesday May 22, 2012 12:50PM
- FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1 Business Wire | Monday May 21, 2012 8:00AM
- Merck to Present at Bank of America Merrill Lynch 2012 Healthcare Conference Business Wire | Wednesday May 16, 2012 8:00AM
- Merck to Present at Deutsche Bank 37th Annual Health Care Conference Business Wire | Tuesday May 8, 2012 8:00AM
- The ups and downs of the weight-loss business Globe and Mail | Monday May 7, 2012 3:00PM
- At the open: Dow, TSX retreat Globe and Mail | Monday April 30, 2012 10:13AM
- Merck Wins U.S. ZETIA® (ezetimibe)/ VYTORIN® (ezetimibe/simvastatin) Patent Infringement Lawsuit Business Wire | Friday April 27, 2012 6:05PM
- At the open: Dow, TSX see slight gains Globe and Mail | Friday April 27, 2012 10:04AM
- Merck Announces First-Quarter 2012 Financial Results Business Wire | Friday April 27, 2012 7:00AM
- Merck Reports Phase III Study Results Evaluating Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy Business Wire | Thursday April 19, 2012 7:00AM
- Merck Wins Another FOSAMAX® (alendronate sodium) State Court Trial Business Wire | Wednesday April 18, 2012 3:42PM
- Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide (EC145) Business Wire | Monday April 16, 2012 7:06AM
- Randy Jackson Partners with Merck to Urge People with Type 2 Diabetes to Take Their Diabetes to Heart PR Newswire | Tuesday April 3, 2012 8:00AM
- Efficacy and Safety Data for ZOSTAVAX® (Zoster Vaccine Live), Merck's Shingles Vaccine, in Adults Ages 50 to 59 Published in Clinical Infectious Diseases Business Wire | Monday April 2, 2012 9:04AM
- Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer Business Wire | Wednesday March 28, 2012 9:30AM
Live Discussion of MRK on StockTwits